← back to search

Lynn H. Gerber

Inova Health System · US
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Myofascial pain diagnosis and treatment, and Cancer survivorship and care.
h-index
67
citations
21,046
works
428
NIH funding
primary concept
Medicine
email

Recent publications

Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis
Gastroenterology 2025cited by 110position: middledoi
Association of food insecurity with MASLD prevalence and liver-related mortality
Journal of Hepatology 2025cited by 45position: contributordoi
“Weekend Warrior” Exercise Pattern Protects Against <scp>MASLD</scp> and Mortality Comparable to Regular Exercise: National Cohort Study
Liver International 2025cited by 7position: middledoi
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
JHEP Reports 2024cited by 29position: middledoi
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
JHEP Reports 2024cited by 26position: contributordoi
A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease
Hepatology 2024cited by 23position: contributordoi
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Journal of Hepatology 2023cited by 94position: middledoi
Systematic Review of Functional Outcomes in Cancer Rehabilitation
Archives of Physical Medicine and Rehabilitation 2022cited by 78position: middledoi
Translating 2019 ACSM Cancer Exercise Recommendations for a Physiatric Practice: Derived Recommendations from an International Expert Panel.
2022cited by 6position: contributordoi
Advancing the global public health agenda for NAFLD: a consensus statement
Nature Reviews Gastroenterology & Hepatology 2021cited by 722position: middledoi
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
2021cited by 28position: contributordoi
Myofascial Pain Syndrome: A Narrative Review Identifying Inconsistencies in Nomenclature.
2020cited by 13position: contributordoi
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
Medicine & Science in Sports & Exercise 2019cited by 2,842position: middledoi
American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control
Medicine & Science in Sports & Exercise 2019cited by 842position: middledoi
Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer
CA A Cancer Journal for Clinicians 2019cited by 790position: middledoi
Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer.
2019cited by 535position: contributordoi
An Executive Summary of Reports From an International Multidisciplinary Roundtable on Exercise and Cancer: Evidence, Guidelines, and Implementation
Rehabilitation Oncology 2019cited by 48position: middledoi
Aerobic capacity and exercise performance in nonalcoholic fatty liver disease.
2019cited by 19position: contributordoi
A scoping review of burn rehabilitation publications incorporating functional outcomes.
2019cited by 12position: contributordoi
Identifying Gaps in Research on Rehabilitation for Patients With Head and Neck Cancer: A Scoping Review.
2019cited by 11position: contributordoi
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
BMC Musculoskeletal Disorders 2016cited by 27position: middledoi
Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C
Clinical Gastroenterology and Hepatology 2013cited by 93position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2019–2025)Kathryn H. Schmitz · UPMC Hillman Cancer Center5 papers (2019–2019)Kerri M. Winters‐Stone · Radboud Institute for Molecular Life Sciences5 papers (2019–2019)Charles E. Matthews · 4 papers (2019–2019)Zobair M. Younossi · NIHR Birmingham Biomedical Research Centre4 papers (2013–2025)Kristin L. Campbell · University of British Columbia4 papers (2019–2019)Alpa V. Patel · American Cancer Society4 papers (2019–2019) · 4 papers (2019–2019)Catherine M. Alfano · Northwell Health3 papers (2019–2022)Trisha F. Hue · University of California, San Francisco3 papers (2019–2019)Nicole L. Stout · West Virginia University3 papers (2019–2022)Anna L. Schwartz · Coleman University3 papers (2019–2019)Linda Henry · Center for Outcomes Research in Liver Diseases2 papers (2013–2025)Anne M. May · Utrecht University2 papers (2019–2019) · 2 papers (2024–2025)Jeffrey V. Lazarus · Barcelona Institute for Global Health2 papers (2024–2025)Martijn M. Stuiver · Utrecht University2 papers (2019–2019)Shira Zelber‐Sagi · Tel Aviv University2 papers (2025–2025)Jennifer A. Ligibel · Harvard University2 papers (2019–2019)William Bain · Pulmonary and Allergy Associates1 papers (2019–2019)